Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTekCapital Regulatory News (TEK)

Share Price Information for TekCapital (TEK)

Share Price is delayed by 15 minutes
Get Live Data
5.80    -0.10 (-1.69%)
Bid:
5.70
Ask:
5.90
Spread: 0.20 (3.509%)
Market Cap: £14.92m
TEK Live PriceLast checked at - London Stock Exchange

Intraday TekCapital Share Chart

Share Options

16 Sep 2019 09:07

RNS Number : 4218M
Tekcapital plc
16 September 2019
 

Tekcapital Plc

 

("Tekcapital" or the "Company")

 

Grant of Share Options

 

Tekcapital Plc (AIM: TEK), the UK intellectual property (IP) investment group focused on creating marketplace value from investing in university technology, announces that on 13 September 2019 it awarded a total of 2,850,000 options over ordinary shares of 0.4 pence each in the Company ('Ordinary Shares'). A total of 100,000 options have been granted under the Company's Enterprise Management Incentive Scheme ("EMI Scheme") and 2,750,000 non qualifying options have been awarded to certain directors and consultants of the Company (the Non-qualifying Options together with the EMI Options, being the "Options").

These Options will have an exercise price of 7.83 pence, being the closing mid-market price on 30 August 2019, and they are subject to performance criteria (the criteria requiring a growth in NAV of the Company at a minimum of 8% per annum). As agreed by the Remuneration committee, these Options will vest when the Company as a whole achieves success in some readily measurable way.

 A total of 300,000 Options have been awarded to the following directors:

Director

No. of options granted

Existing no. of options

Option Type

Total no. of options over Ordinary Shares ('Total Options')

Total Options as a percentage of the Company's issued share capital

 

Robert Miller

100,000

220,000

Non-EMI

320,000

0.502%

Bill Payne

100,000

220,000

Non-EMI

320,000

0.502%

Malcom Groat

100,000

100,000

Non-EMI

200,000

0.314%

 

Following the issue of the new Options, the total number of Ordinary Shares under option which could be issued if the performance criteria is met is 5,468,333 Ordinary Shares representing 8.58% of the Company's issued share capital.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them are set out below pursuant to the EU Market Abuse regulation.

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

a)

 

Name

Robert Miller

Bill Payne

Malcom Groat

2

 

Reason for the notification

a)

 

Position/status

 

See 1 a) above

b)

 

Initial notification /

Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

 

Name

 

TEKCAPITAL PLC

b)

 

LEI

 

213800GOJTOV19FIFZ85 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of

instrument

 

Identification code

 

Ordinary Shares of 0.4p each

 

 

 

ISIN: GB00BKXGY798

 

b)

 

Nature of the transaction

 

Grant of options over ordinary shares

c)

 

Price(s) and volume(s)

 

 

 

Director/PDMR

 Price(s)

Volume(s)

Robert Miller

7.83p per share

100,000

Bill Payne

 

7.83p per share

100,000

Malcom Groat

7.83p per share

100,000

 

 

d)

 

Aggregated information

- Aggregated volume

- Price

 

 

Price(s)

Volume(s)

7.83p per share

300,000

 

e)

 

Date of the transaction

 

30 August 2019

f)

 

Place of the transaction

 

Outside a trading venue

 

For further information, please contact:

Tekcapital Plc 

Via Yellow Jersey PR 

Clifford M. Gross, Ph.D. 

finnCap Ltd (Nominated Adviser and Joint Broker)

+44 (0) 20 7220 0500 

Geoff Nash/ Max Bullen-Smith (Corporate Finance)

Camille Gochez (ECM) 

Novum Securities Limited (Joint Broker) 

+44 (0) 20 7399 9427

Colin Rowbury (Corporate Broking) 

Yellow Jersey Limited

+44 (0) 20 3004 9512 

Sarah Hollins/ Annabel Atkins 

tekcapital@yellowjerseypr.com 

 

About Tekcapital plc

Tekcapital creates value from investing in new, university-developed intellectual properties and provides a range of IP investment services to make it easy for organisations to commercialise university-developed technology. Tekcapital is quoted on the AIM market of the London Stock Exchange (AIM: symbol TEK) and is headquartered in Oxford, in the UK. For more information, please visit www.tekcapital.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHGMGMLRVGGLZG
Date   Source Headline
27th May 20267:00 amRNSResults for Year Ended 31 December 2025
22nd May 20267:00 amRNSTekcapital takes stake in geothermal AI firm
21st May 20267:00 amRNSNew Orders
28th Apr 20267:00 amRNSStrategic Resale Alliance with Cardinal IP
18th Feb 20267:00 amRNSNotification of Major Holdings
10th Feb 20267:00 amRNSConditional Placing of £1.5 million
15th Jan 20267:00 amRNSCorporate Update
7th Jan 20267:00 amRNS-RPorfolio Company Update - Innovative Eyewear Inc
12th Dec 20257:00 amRNS-RPortfolio Company Update - Innovative Eyewear Inc
1st Dec 20257:00 amRNS-RPortfolio Company Update - Innovative Eyewear
19th Nov 20257:00 amRNSPortfolio Company Update - Guident Corp
13th Nov 20257:00 amRNSInnovative Eyewear Q3 Unaudited Financial Results
13th Nov 20257:00 amRNSTrading Statement
10th Nov 20257:00 amRNS-RStrategic Alliance signed with Nexscient Inc
4th Nov 20257:00 amRNS-RPortfolio Company Update - Innovative Eyewear
17th Oct 20254:15 pmRNSNotification of Major Holdings
13th Oct 20251:44 pmRNSPlacing of £0.37 Million
10th Oct 20257:00 amRNSNew Product Launch – Invention Validator
8th Oct 202510:53 amRNSReplacement - Unaudited Half-Yearly Report
7th Oct 20257:00 amRNS-RPortfolio Company Update Innovative Eyewear
6th Oct 20257:00 amRNSReplacement RNS: Half-year Report
30th Sep 20257:02 amRNSCommercial Strategy Update & New Products
30th Sep 20257:00 amRNSHalf-year Report
25th Sep 20257:00 amRNS-RPortfolio Company Update -Guident
24th Sep 20257:00 amRNSUnaudited Half Yearly Report
18th Sep 20257:00 amRNSPortfolio Company Update -Guident Proposed US IPO
10th Sep 20257:00 amRNS-RPortfolio Company Update - Innovative Eyewear
29th Aug 20257:00 amRNS-RPortfolio Company Update Guident Corp
19th Aug 20257:00 amRNS-RPortfolio Company Update - Guident Corp
15th Aug 20257:00 amRNS-RPortfolio Company Update Innovative Eyewear Q2
13th Aug 20257:00 amRNS-RPortfolio Company Update - Guident Corp
6th Aug 20257:00 amRNS-RPortfolio Company Update - Guident Corp
25th Jul 20257:00 amRNSTrading Statement
24th Jul 20257:00 amRNS-RPortfolio Company Update - Guident Corp
21st Jul 20257:00 amRNS-RPortfolio Company Update- Innovative Eyewear
27th Jun 202512:39 pmRNSResult of AGM
19th Jun 20251:06 pmRNSNotification of Major Holdings
19th Jun 202511:07 amRNSHolding(s) in Company - Replacement
19th Jun 20257:00 amRNS-RPortfolio Company Update - Guident Corp
10th Jun 20257:00 amRNSContract Win
2nd Jun 20257:02 amRNSNotice of AGM
2nd Jun 20257:00 amRNSFinal Results Year Ended 31 December Notice of AGM
2nd Jun 20257:00 amRNSFundraising of £1.25 Million
29th May 20257:00 amRNS-RPortfolio Company Update - Innovative Eyewear Inc
23rd May 20257:00 amRNSFinal Results Year Ended 31 December 2024
16th May 20257:00 amRNS-RPortfolio Company Update - Guident Corp
12th May 20257:00 amRNSPortfolio Company Update:Guident Corp Proposed IPO
6th May 20257:00 amRNSPortfolio Company Update - Innovative Eyewear Inc.
28th Apr 20257:00 amRNSPortfolio Company Update - Innovative Eyewear Inc
24th Apr 20257:00 amRNSQ1 2025 Business Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.